Related references
Note: Only part of the references are listed.Clinical significance of epithelial-mesenchymal transition markers in prostate cancer
Sandy Figiel et al.
HUMAN PATHOLOGY (2017)
Interplay Between Long Noncoding RNA ZEB1-AS1 and miR-200s Regulates Osteosarcoma Cell Proliferation and Migration
Chibo Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
Karen Hanrahan et al.
MOLECULAR ONCOLOGY (2017)
被撤回的出版物: Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma (Retracted article. See vol. 41, pg. 4839, 2022)
T. Li et al.
ONCOGENE (2016)
A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma
Qiao-Li Lv et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2014)
MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1
Takehiko Yokobori et al.
CANCER SCIENCE (2013)
Sequential Inductions of the ZEB1 Transcription Factor Caused by Mutation of Rb and Then Ras Proteins Are Required for Tumor Initiation and Progression
Yongqing Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state
Christos Polytarchou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Long non-coding RNAs and enhancers
Ulf Andersson Orom et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer
Francesco Crea et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal Transition
Natlia Dave et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Transcriptional Activation of ZEB1 by Slug Leads to Cooperative Regulation of the Epithelial-Mesenchymal Transition-Like Phenotype in Melanoma
Christian Wels et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
Erin N. Howe et al.
BREAST CANCER RESEARCH (2011)
BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma
Nageatte Ibrahim et al.
CANCER RESEARCH (2010)
MicroRNA145 Targets BNIP3 and Suppresses Prostate Cancer Progression
Xueqin Chen et al.
CANCER RESEARCH (2010)
Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation
Rita U. Lukacs et al.
CELL STEM CELL (2010)
The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer?
Simone Brabletz et al.
EMBO REPORTS (2010)
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Yohei Shimono et al.
CELL (2009)
Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression
Gregory J. Hurteau et al.
CELL CYCLE (2009)
Delta-Crystallin Enhancer Binding Factor 1 Controls the Epithelial to Mesenchymal Transition Phenotype and Resistance to the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Human Head and Neck Squamous Cell Carcinoma Lines
Yasmine Haddad et al.
CLINICAL CANCER RESEARCH (2009)
Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer
Yoshihiro Adachi et al.
FEBS LETTERS (2009)
BCL-xL Is a Target Gene Regulated by Hypoxia-inducible Factor-1α
Ni Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
ZEB-1, a Repressor of the Semaphorin 3F Tumor Suppressor Gene in Lung Cancer Cells
Jonathan Clarhaut et al.
NEOPLASIA (2009)
Insulin-like growth factor-l-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells
Tisheeka R. Graham et al.
CANCER RESEARCH (2008)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
ZEB1 expression in type I vs type II endometrial cancers:: a marker of aggressive disease
Meenakshi Singh et al.
MODERN PATHOLOGY (2008)
Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription
Xiangting Wang et al.
NATURE (2008)
Bidirectional Transcription Directs Both Transcriptional Gene Activation and Suppression in Human Cells
Kevin V. Morris et al.
PLOS GENETICS (2008)
Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4
Michiel Vermeulen et al.
CELL (2007)
Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features
Geert J. L. H. van Leenders et al.
EUROPEAN UROLOGY (2007)
A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced
Julie Chaumeil et al.
GENES & DEVELOPMENT (2006)
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B
B Krishnamachary et al.
CANCER RESEARCH (2006)
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
GV Glinsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Share Paper
